Abstract: Disclosed herein are system, method, and computer program product embodiments for enhancing parameter-less exit-calls from a command line interface (CLI). An embodiment operates by obtaining a parameter and a name for a task script, and then generating a shell script including the name of the task script and an instruction to execute the task script based on the parameter. Then, an execution request for a task including an exit-call is sent to the CLI. The execution request includes a name of the shell script for the exit-call. The CLI calls the shell script in response to the exit-call during execution of the task. Further, the task script is executed based on the parameter in response to the CLI calling the shell script.

Abstract: Apparatuses, methods and computer programs for a transportation vehicle and a central office. The apparatus includes a communication module for communication with a central office and a computation module for controlling the communication module. The computation module receives a partial task of a distributed data processing from the central office, computes the partial task of the distributed data processing to obtain a result of the partial task, and provides the result of the partial task for the central office.

Abstract: Disclosed herein are system, method, and computer program product embodiments for enhancing parameter-less exit-calls from a command line interface (CLI). An embodiment operates by obtaining a parameter and a name for a task script, and then generating a shell script including the name of the task script and an instruction to execute the task script based on the parameter. Then, an execution request for a task including an exit-call is sent to the CLI. The execution request includes a name of the shell script for the exit-call. The CLI calls the shell script in response to the exit-call during execution of the task. Further, the task script is executed based on the parameter in response to the CLI calling the shell script.

Abstract: Disclosed herein are system, apparatus, method, and computer program product embodiments for securing inter-network communications. An embodiment operates by generating a task request to be performed in a first network environment. The embodiment further operates by transmitting the task request to an application located in a second network environment. The embodiment further operates by receiving a task package from the application. The embodiment further operates by determining whether the task package includes a positive task value and, if so, calling a task in the first network environment based on the task package. The embodiment further operates by generating a creation status associated with an execution of the task in the first environment and transmitting the creation status to the application. Subsequently, the embodiment further operates by generating a final status associated with the execution of the task and transmitting the final status to the application.

Abstract: Disclosed herein are system, method, and computer program product embodiments for enhancing parameter-less exit-calls from a command line interface (CLI). An embodiment operates by obtaining a parameter and a name for a task script, and then generating a shell script including the name of the task script and an instruction to execute the task script based on the parameter. Then, an execution request for a task including an exit-call is sent to the CLI. The execution request includes a name of the shell script for the exit-call, The CLI calls the shell script in response to the exit-call during execution of the task. Further, the task script is executed based on the parameter in response to the CLI calling the shell script.

Abstract: Disclosed herein are system, apparatus, method, and computer program product embodiments for testing software in a continuous deployment pipeline. An embodiment operates by automatically deploying a second version of an application at an idle endpoint. The embodiment further operates by automatically testing the second version of the application by reusing test metrics associated with a first version of the application that is live at a live endpoint. The embodiment further operates by automatically determining whether the automatic testing of the second version of the application is successful and, if so, automatically setting live the second version of the application. For example, the embodiment can operate by automatically exchanging the live endpoint with the idle endpoint to set live the second version and set idle the first version, which then may be placed in termination.

Abstract: Disclosed herein are system, apparatus, method, and computer program product embodiments for testing software in a continuous deployment pipeline. An embodiment operates by automatically deploying a second version of an application at an idle endpoint. The embodiment further operates by automatically testing the second version of the application by reusing test metrics associated with a first version of the application that is live at a live endpoint. The embodiment further operates by automatically determining whether the automatic testing of the second version of the application is successful and, if so, automatically setting live the second version of the application. For example, the embodiment can operate by automatically exchanging the live endpoint with the idle endpoint to set live the second version and set idle the first version, which then may be placed in termination.

Abstract: The invention relates to a composition, in particular a pharmaceutical composition, which is suitable in particular for the prophylactic and/or therapeutic treatment preferably of inflammatory diseases of the urogenital tract, in particular inflammatory diseases of the bladder, preferably cystitis, to the uses thereof, to a storage or application device relating to same, to a packaging unit, and finally to a kit which is designed in particular as an instillation system.

Abstract: An article of manufacture according to the present invention comprises a composition including a glycosaminoglycan, a local anesthetic, and a buffer packaged in a syringe or vial constructed from either glass or a plastic selected from the group consisting of cyclic olefin polymer, cyclic olefin copolymer, or high density non-nucleated polypropylene. The composition has unexpectedly improved stability on storage. The composition can be formulated for treatment of a urinary tract disease or condition, such as interstitial cystitis, also known as bladder pain syndrome or hypersensitive bladder syndrome.

Abstract: A pocketed spring assembly comprises parallel strings, each string joined to at least one adjacent string. At least some of the strings have springs of different gauge wire and some of the pockets of the strings having springs of different gauge wire are spliced together. At least some of the strings have springs of different geometries and some of the pockets of the strings having springs of different geometries are spliced together. At least some strings may have end sections with springs different than a middle section therebetween, the springs of the end sections being firmer than the springs of the middle section.

Abstract: A pocketed spring assembly comprises parallel strings, each string joined to at least one adjacent string. At least some of the strings have springs of different gauge wire and some of the pockets of the strings having springs of different gauge wire are spliced together. At least some of the strings have springs of different geometries and some of the pockets of the strings having springs of different geometries are spliced together. At least some strings may have end sections with springs different than a middle section therebetween, the springs of the end sections being firmer than the springs of the middle section.

Abstract: Provided are methods for forming a rigid cable harness. An example method includes providing a curable sleeve comprising a curable compound, an adhesive, and a backing; wherein the curable adhesive tape has a longitudinal direction. The method further includes placing a plurality of cables on the sleeve in the longitudinal direction and wrapping the curable sleeve around the placed plurality of cables to form a cable harness, wherein the wrapping comprises wrapping the plurality of cables with the curable sleeve in the longitudinal direction. The method additionally includes positioning the cable harness into a desired shape and curing the curable compound of the cable harness to form the rigid cable harness, wherein the rigid cable harness has the desired shape.

Abstract: The present invention relates to a circuit substrate arrangement comprising a base layer (2) made from aluminium, a circuit layer (3) made from copper, a dielectric layer (4) arranged between the base layer (2) and the circuit layer (3), an opening (5) passing through the base layer (2), the circuit layer (3) and the dielectric layer (4) and an electrical contact (6) between the base layer (2) and the circuit layer (3), wherein the electrical contact (6) comprises a rivet (7), wherein a frictionally connected joint (8) is formed between the rivet (7) and the base layer (2) and wherein an integrally bonded joint (9) is formed between the rivet (7) and the circuit layer (3).

Abstract: The invention relates to a combination drug with increased storage stability containing chondroitin sulfate (4.5 mg/ml), hyaluronic acid (16 mg/ml), a phosphate buffer (pH 6.1 to 7.9) and an electrolyte (e.g., an alkali salt, e.g., sodium chloride) for the treatment inflammations of the urogenital tract, in particular of the bladder, in particular for the treating cystitis, and to an instillation kit containing said drug.

Abstract: The invention relates to a composition, in particular a pharmaceutical composition, which is suitable in particular for the prophylactic and/or therapeutic treatment preferably of inflammatory diseases of the urogenital tract, in particular inflammatory diseases of the bladder, preferably cystitis, to the uses thereof, to a storage or application device relating to same, to a packaging unit, and finally to a kit which is designed in particular as an instillation system.

Abstract: A crosslapper, a process and a formed fabric web shielding device for a cross lapper shield a formed fabric web moved in the crosslapper. The formed fabric web has a bottom side, a top side and side surfaces located at formed fabric longitudinal edges. The crosslapper includes a displaceable main carriage and a crosslapper laying belt feeding the formed fabric web in a web direction to the displaceable main carriage with the formed fabric web bottom side located on the cross lapper laying belt. The shielding device includes a housing configured to be arranged in the crosslapper and configured to cover the side surfaces of the formed fabric web located on the laying belt and being fed to the displaceable main carriage, which side surfaces extend along the web direction, to shield the side surfaces of the formed fabric web against external environmental effects.

Abstract: The present invention relates to a circuit substrate arrangement comprising a base layer (2) made from aluminium, a circuit layer (3) made from copper, a dielectric layer (4) arranged between the base layer (2) and the circuit layer (3), an opening (5) passing through the base layer (2), the circuit layer (3) and the dielectric layer (4) and an electrical contact (6) between the base layer (2) and the circuit layer (3), wherein the electrical contact (6) comprises a rivet (7), wherein a frictionally connected joint (8) is formed between the rivet (7) and the base layer (2) and wherein an integrally bonded joint (9) is formed between the rivet (7) and the circuit layer (3).

Abstract: The invention relates to an adhesive tape in particular for wrapping cables, consisting of a preferably textile carrier and of a pressure sensitive adhesive, applied on at least one side of the carrier, in the form of a dried polymer dispersion, the polymer having been synthesized from: (a) 70.0 to 90.0 wt % of n-butyl acrylate and/or 2-ethylhexyl acrylate (b) 10.0 to 20.0 wt % of one or more ethylenically unsaturated monomers, where at least 50.0 wt % of the ethylenically unsaturated monomers (monomer (b)) comprises methyl methacrylate (c) 0 to 10.0 wt % of a further ethylenically unsaturated monomer, different from monomer (b) (d) 0 to 5.0 wt % of an ethylenically unsaturated monomer having an acid or acid-anhydride function and the pressure sensitive adhesive comprises between 3 and 20 parts by weight of tackifiers (based on the mass of the dried polymer dispersion), the tackifiers having a softening point of more than 90° C. according to ASTM E29-99 (2009).

Abstract: A monitoring process is provided for a method for producing a nonwoven product. Properties of a nonwoven pre-product (3), in particular the humidity, the electric charge, the weight distribution, the fiber orientation, the fiber mixing ratio and/or the fiber opening degree of an unprocessed fiber web, are detected by a detection unit (41) having one or more sensors (410).

Abstract: A monitoring process is provided for a method for producing a nonwoven fabric (7) made of fibers (1, 2) in a nonwoven fabrication plant (15). Humidity and/or the electric charge of the fibers (1, 2) or a nonwoven pre-product (3) is detected by a detection unit (41) in a detection zone (5) and the detection results are processed in a data processing unit (42). An actuation command (45) is generated for at least one actuation unit (50) of the nonwoven fabrication plant (15). The actuation unit (50) is configured to set the humidity of the fibers (1, 2) and/or the humidity of the nonwoven pre-product (3) and/or the ambient conditions in at least one portion of the nonwoven pre-production plant (10).